PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Precision Medicine, Medical and Life Sciences Faculty, Furtwangen University, Jakob-Kienzle-Str. 17, D-78054 Villingen-Schwenningen, Germany.\', \'Institute of Pharmaceutical Sciences, University of Freiburg, Albertstraße 25, D-79104 Freiburg, Germany.\', \'Department of Anesthesiology and Intensive Care Medicine, University of Rostock, Schillingallee 35, D-18057 Rostock, Germany.\', \'Department of Intensive Care Medicine, Hospital of Magdeburg, Birkenallee 34, D-39130 Magdeburg, Germany.\', \'Fraunhofer Institute IZI, Leipzig, EXIM Department, Schillingallee 68, D-18057 Rostock, Germany.\', \'Organic Chemistry, Martin-Luther-University Halle-Wittenberg, Kurt-Mothes-Str. 2, D-06120 Halle (Saale), Germany.\', \'Associated Member, Faculty of Science, Tuebingen University, Auf der Morgenstelle 8, D-72076 Tübingen, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • E495310.3390/ijms21144953
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 32668803
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all